Ann: Emyria Gets $2M Bids, Sets $3.1M Entitlement Offer, page-27

Imo there's a few clear reasons. S/p could easily fall back down from 10c, however, I believe it was oversold beyond 10c, and so did management, who knew full well a raise was imminent when buying on market recently.

- Cash concerns now alleviated with cornerstone participation from long term supporter.
- Expectation that entitlement offer will be well supported by long-term investors. Especially with the incentive of options attached
- Concerns about RX5 were cleared up and rough timeline one outcomes provided
- Launch of MDMA assisted therapy via the profitable Pax Centre
- A bullish newsletter, apparently.

All imo etc but $5m seems like the ideal amount to raise given what's in the pipeline this financial year.